BACM
TEVA icon

Blue Arrow Capital Management’s Teva Pharmaceuticals TEVA Stock Holding History

Blue Arrow Capital Management’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q4 		– Sell
-30,000
Closed -$1.61M – 239
2014
Q3 		$1.61M Buy
+30,000
New +$1.59M 0.17% 129

Other funds holding TEVA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Lazard Asset Management
Lazard Asset Management New York $66.1B AUM 33.53% 1-Year Est. Return
WRF
Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return
MIP
Mondrian Investment Partners London, United Kingdom $6.48B AUM 18.36% 1-Year Est. Return
BA
BlackRock Advisors Wilmington, Delaware $98.8B AUM 15.8% 1-Year Est. Return
Barrow, Hanley, Mewhinney & Strauss
Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $33B AUM 40.62% 1-Year Est. Return
Allianz Asset Management
Allianz Asset Management Munich, Germany $112B AUM 36.28% 1-Year Est. Return
PC
PointState Capital New York $7.82B AUM 43.51% 1-Year Est. Return

Blue Arrow Capital Management's TEVA Position: Q2 2015 in Review

Blue Arrow Capital Management sold out of Teva Pharmaceuticals (TEVA) in Q2 2015, closing a stake of 92,000 shares — an estimated $5.73M sold.

Blue Arrow Capital Management first reported a position in TEVA in Q3 2014 and held it in 3 quarters. The position peaked at $5.73M in Q1 2015. 819 funds tracked by Wall St. Rank hold TEVA as of Q2 2015.

  • Blue Arrow Capital Management reported no remaining Teva Pharmaceuticals position as of Q2 2015 after selling out during the quarter.
  • Blue Arrow Capital Management sold 92,000 Teva Pharmaceuticals shares in Q2 2015, an estimated $5.73M.
  • Blue Arrow Capital Management first reported a position in Teva Pharmaceuticals in Q3 2014 and held it in 3 quarters.
  • Blue Arrow Capital Management's Teva Pharmaceuticals position peaked at $5.73M in Q1 2015.
  • 819 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q2 2015.

Based on Blue Arrow Capital Management's 13F filing for Q2 2015, filed 14 Aug 2015.